Financials

  • Market Capitalization 306.99 M
  • Employee 28
  • Founded 2018
  • CEO N/A
  • Website www.opusgtx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BT34Q3
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.09
ratio cours/chiffre d'affaires
29.93

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3265
VNDA
Vanda Pharmaceuticals Inc. - Common Stock
5.29 USD-2.76%-0.94%+2.52%-4.34%319.85 M USD
3293
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
5.19 USD+1.57%-2.99%+30.40%+92.22%311.95 M USD
3341
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.85 USD0.00%+0.26%+3.22%-39.84%293.74 M USD
3344
TTRX
Turn Therapeutics Inc. - Common Stock
9.84 USD-2.67%+4.79%+17.70%-1.60%293.11 M USD